Skip to main content
Top
Published in: Cancer Causes & Control 2/2018

01-02-2018 | Original paper

The performance of mobile screening units in a breast cancer screening program in Brazil

Authors: Z. R. Greenwald, J. H. Fregnani, A. Longatto-Filho, A. Watanabe, J. S. C. Mattos, F. L. Vazquez, E. L. Franco

Published in: Cancer Causes & Control | Issue 2/2018

Login to get access

Abstract

Purpose

In Brazil, access to breast cancer screening outside of urban centers is limited. This study aims to describe the coverage and performance of a breast cancer screening program implemented with Mobile Screening Units (MSU) in northern São Paulo state.

Methods

This is a retrospective cohort study of a population-based mammography program targeting women ages 40–69 in 108 municipalities from 12/2010 to 07/2015. Screening coverage rates were estimated using the Brazil 2010 census data. We calculated performance measures for the number of exams, recalls, and detected cases of cancer. Screen-detected cases were compared to clinically detected cases using hospital cancer registry data and a propensity-score matching method. The down-staging of screen-detected cases relative to clinically detected cases was assessed using logistic regression to calculate risk ratios (RRs) with 95% confidence intervals.

Results

122,634 women were screened through the MSU program, representing a cumulative coverage rate of 54.8% in the target population. For initial and subsequent rounds, recall rates were 12.25 and 6.10% and cancer detection rates were 3.63 (95% CI 3.23–4.10) and 1.94 (95% CI 1.59–2.41), respectively. 92.51% of referrals were successful. Screen-detected cases had more favorable prognoses than clinically detected cases, including smaller tumor size and a decreased risk of late-stage detection (RR 0.14 95% CI 0.074–0.25).

Conclusions

MSUs are a feasible method for the delivery of mammography services in this setting. Patients who had breast cancer detected on an MSU had favorable prognostic factors when compared with clinically detected cases arising from the same target population.
Appendix
Available only for authorised users
Literature
3.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed 4 September 2015 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer. http://​globocan.​iarc.​fr. Accessed 4 September 2015
6.
8.
go back to reference INCA (2011) Sistemas de informação do controle do câncer de mama (SISMAMA) e do câncer do colo do útero (SISCOLO): manual gerencial. Instituto Nacional de Câncer. Coordenação Geral de Ações Estratégicas, Rio de Janeiro INCA (2011) Sistemas de informação do controle do câncer de mama (SISMAMA) e do câncer do colo do útero (SISCOLO): manual gerencial. Instituto Nacional de Câncer. Coordenação Geral de Ações Estratégicas, Rio de Janeiro
9.
go back to reference Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, Bannon F, Ahn JV, Johnson CJ, Bonaventure A (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, Bannon F, Ahn JV, Johnson CJ, Bonaventure A (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed
10.
go back to reference De Castro Mattos JS, Caleffi M, Da Costa Vieira RE (2013) Rastraemento mamográfico no Brasil: resultados preliminares. Rev Brasil Mastol 23(1):22–27 De Castro Mattos JS, Caleffi M, Da Costa Vieira RE (2013) Rastraemento mamográfico no Brasil: resultados preliminares. Rev Brasil Mastol 23(1):22–27
11.
go back to reference Marchi AA, Gurgel MSC (2010) Adesão ao rastreamento mamográfico oportunístico em serviços de saúde públicos e privados. Rev Brasil de Ginecol e Obstetr 32:191–197 Marchi AA, Gurgel MSC (2010) Adesão ao rastreamento mamográfico oportunístico em serviços de saúde públicos e privados. Rev Brasil de Ginecol e Obstetr 32:191–197
13.
go back to reference Mauad EC, Nicolau SM, Moreira LF, Haikel RL, Longatto-Filho A, Baracat EC (2009) Adherence to cervical and breast cancer programs is crucial to improving screening performance. Rural Remote Health 9(3):1241–1241PubMed Mauad EC, Nicolau SM, Moreira LF, Haikel RL, Longatto-Filho A, Baracat EC (2009) Adherence to cervical and breast cancer programs is crucial to improving screening performance. Rural Remote Health 9(3):1241–1241PubMed
14.
go back to reference Silva TB, Mauad EC, Carvalho AL, Jacobs LA, Shulman LN (2013) Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods. Rural Remote Health 13(2):2321PubMed Silva TB, Mauad EC, Carvalho AL, Jacobs LA, Shulman LN (2013) Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods. Rural Remote Health 13(2):2321PubMed
16.
go back to reference Tsunoda A, Fregnani J, Oliveira J, Alencar M, Brentani R, Mauad E (2009) Quality performance indicators in breast cancer screening and treatment in a Brazilian non-metropolitan setting. Int J Gynecol Obstet 107:S608CrossRef Tsunoda A, Fregnani J, Oliveira J, Alencar M, Brentani R, Mauad E (2009) Quality performance indicators in breast cancer screening and treatment in a Brazilian non-metropolitan setting. Int J Gynecol Obstet 107:S608CrossRef
17.
go back to reference Souza Sabino S, Silva TB, Watanabe AH, Syrjanen K, Carvalho AL, Mauad EC (2014) Implementation of a clinical quality control program in a mammography screening service of Brazil. Anticancer Res 34(9):5057–5065 Souza Sabino S, Silva TB, Watanabe AH, Syrjanen K, Carvalho AL, Mauad EC (2014) Implementation of a clinical quality control program in a mammography screening service of Brazil. Anticancer Res 34(9):5057–5065
18.
go back to reference Sickles E, D’Orsi C, Bassett L, al. e (2013) ACR BI-RADS® mammography. In: ACR BI-RADS® Atlas, breast imaging reporting and data system. American College of Radiology, Reston Sickles E, D’Orsi C, Bassett L, al. e (2013) ACR BI-RADS® mammography. In: ACR BI-RADS® Atlas, breast imaging reporting and data system. American College of Radiology, Reston
19.
go back to reference IBGE (2013) Atlas do censo demográfico 2010. IBGE, Rio de Janeiro IBGE (2013) Atlas do censo demográfico 2010. IBGE, Rio de Janeiro
21.
go back to reference Perry N, Broeders M, De Wolf C, Törnberg S, Holland R, von Karsa L, Puthaar E (2006) European guidelines for quality assurance in breast cancer screening and diagnosis Fourth Edition. Office for Official Publications of the European Communities, Luxembourg Perry N, Broeders M, De Wolf C, Törnberg S, Holland R, von Karsa L, Puthaar E (2006) European guidelines for quality assurance in breast cancer screening and diagnosis Fourth Edition. Office for Official Publications of the European Communities, Luxembourg
22.
go back to reference Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D (2002) AJCC cancer staging handbook, 6th edn. Springer, New YorkCrossRef Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D (2002) AJCC cancer staging handbook, 6th edn. Springer, New YorkCrossRef
23.
go back to reference Peto R, Pike M, Armitage P, Breslow NE, Cox D, Howard S, Mantel N, McPherson K, Peto J, Smith P (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 35(1):1CrossRefPubMedPubMedCentral Peto R, Pike M, Armitage P, Breslow NE, Cox D, Howard S, Mantel N, McPherson K, Peto J, Smith P (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 35(1):1CrossRefPubMedPubMedCentral
25.
go back to reference StataCorp (2015) Stata statistical software: release 14. StataCorp LP, College Station StataCorp (2015) Stata statistical software: release 14. StataCorp LP, College Station
26.
go back to reference World Health Organization (2007) Cancer control knowledge into action. WHO guide for effective programmes. Early Detection, vol 2. World Health Organization, Geneva World Health Organization (2007) Cancer control knowledge into action. WHO guide for effective programmes. Early Detection, vol 2. World Health Organization, Geneva
30.
go back to reference Rodriguez-Cuevas S, Guisa-Hohenstein F, Labastida-Almendaro S (2009) First breast cancer mammography screening program in Mexico: initial results 2005–2006. Breast J 15(6):623–631CrossRefPubMed Rodriguez-Cuevas S, Guisa-Hohenstein F, Labastida-Almendaro S (2009) First breast cancer mammography screening program in Mexico: initial results 2005–2006. Breast J 15(6):623–631CrossRefPubMed
31.
go back to reference Garas I, Pateras H, Triandafilou D, Georgountzos V, Mihas A, Abatzoglou M, Trichopoulos D (1994) Breast cancer screening in southern Greece. Eur J Cancer Prev 3(Suppl 1):35–39CrossRefPubMed Garas I, Pateras H, Triandafilou D, Georgountzos V, Mihas A, Abatzoglou M, Trichopoulos D (1994) Breast cancer screening in southern Greece. Eur J Cancer Prev 3(Suppl 1):35–39CrossRefPubMed
32.
go back to reference Séguret F, Daures JP, Guizard AV, Mathieu-Daude H, Bonifacj JC, Cherifcheik J, Lamarque JL (1995) Herault breast screening programme: results after 30 months of a mobile French schedule. Eur J Cancer Prev 4(4):299–305CrossRefPubMed Séguret F, Daures JP, Guizard AV, Mathieu-Daude H, Bonifacj JC, Cherifcheik J, Lamarque JL (1995) Herault breast screening programme: results after 30 months of a mobile French schedule. Eur J Cancer Prev 4(4):299–305CrossRefPubMed
33.
go back to reference Van Oyen H, Verellen W (1994) Breast cancer screening in the Flemish region, Belgium. Eur J Cancer Prev 3(Suppl 1):7–12CrossRefPubMed Van Oyen H, Verellen W (1994) Breast cancer screening in the Flemish region, Belgium. Eur J Cancer Prev 3(Suppl 1):7–12CrossRefPubMed
Metadata
Title
The performance of mobile screening units in a breast cancer screening program in Brazil
Authors
Z. R. Greenwald
J. H. Fregnani
A. Longatto-Filho
A. Watanabe
J. S. C. Mattos
F. L. Vazquez
E. L. Franco
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2018
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0995-7

Other articles of this Issue 2/2018

Cancer Causes & Control 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine